Alinamin Pharmaceutical Overview

Medical ProductsCompany

Is Alinamin Pharmaceutical PE-backed?

Yes. Alinamin Pharmaceutical is owned by private equity investors CPP Investments and MBK Partners.

Was Alinamin Pharmaceutical formerly PE-backed?

Yes. Alinamin Pharmaceutical was formerly owned by 1 private investor.

Where is Alinamin Pharmaceutical headquartered?

Alinamin Pharmaceutical is headquartered in Tokyo, Japan.

What sector is Alinamin Pharmaceutical in?

Alinamin Pharmaceutical is a medical products company.

When was Alinamin Pharmaceutical founded?

Alinamin Pharmaceutical was founded in 2016.

Alinamin Pharmaceutical

Alinamin Pharmaceutical Co., Ltd.

Tokyo,
Japan,

Alinamin Pharmaceutical is an OTC and consumer healthcare company. Alinamin Pharmaceutical was founded in 2016 and is based in Tokyo, Japan.



Try Mergr Free — See This and 221,165+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Alinamin Pharmaceutical

Medical Products Companies , Japan Companies